ESMYX
Price
$14.20
Change
+$0.23 (+1.65%)
Updated
Jan 21 closing price
Net Assets
152.41M
VEURX
Price
$35.73
Change
+$0.75 (+2.14%)
Updated
Jan 21 closing price
Net Assets
22.02B
Ad is loading...

ESMYX vs VEURX

Header iconESMYX vs VEURX Comparison
Open Charts ESMYX vs VEURXBanner chart's image
Invesco EQV Euro Small Company Y
Price$14.20
Change+$0.23 (+1.65%)
VolumeN/A
Net Assets152.41M
Vanguard European Stock Investor
Price$35.73
Change+$0.75 (+2.14%)
VolumeN/A
Net Assets22.02B
ESMYX vs VEURX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ESMYX vs. VEURX commentary
Jan 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESMYX is a Hold and VEURX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEURX has more cash in the bank: 22B vs. ESMYX (152M). ESMYX pays higher dividends than VEURX: ESMYX (4.43) vs VEURX (3.11). ESMYX was incepted earlier than VEURX: ESMYX (16 years) vs VEURX (35 years). ESMYX is a more actively managed with annual turnover of: 24.00 vs. VEURX (4.00). VEURX has a lower initial minimum investment than ESMYX: VEURX (0) vs ESMYX (1000). VEURX annual gain was more profitable for investors over the last year : 6.34 vs. ESMYX (1.29). ESMYX (15.55) and VEURX (15.03) have equivalent 5 years return.
ESMYXVEURXESMYX / VEURX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years35 years-
Gain YTD1.5744.53535%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets152M22B1%
Annual Yield % from dividends4.433.11142%
Returns for 1 year1.296.3420%
Returns for 3 years-9.171.17-781%
Returns for 5 years15.5515.03103%
Returns for 10 years53.1729.76179%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTLP8.290.14
+1.72%
Cantaloupe
BATRK38.070.49
+1.30%
Atlanta Braves Holdings
SONN1.54N/A
N/A
Sonnet BioTherapeutics Holdings Inc
SRPT116.79-1.21
-1.03%
Sarepta Therapeutics
AHG1.49-0.05
-3.25%
Akso Health Group ADS